If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Recognising the pressing need for new therapies, the FDA has already granted a fast-track designation to zolbetuximab for the treatment of gastric and GEJ adenocarcinoma. Other companies ...
The most common type of stomach cancer is adenocarcinoma. A combination of structural and cell biology studies reveals the molecular mechanism how bozitinib inhibits c-Met and highlights its ...